1-5 of 5
David G. Maggs
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effects of Pramlintide on Postprandial Glucose Excursions and Measures of Oxidative Stress in Patients With Type 1 Diabetes

Free
Antonio Ceriello, MD, Ludovica Piconi, PHD, Lisa Quagliaro, PHD, Yan Wang, PHD, Catherine A. Schnabel, PHD, James A. Ruggles, PHD, Maurice A. Gloster, MD, David G. Maggs, MD, Christian Weyer, MD
Journal: Diabetes Care
Diabetes Care 2005;28(3):632–637
https://doi.org/10.2337/diacare.28.3.632
Published: 01 March 2005
View articletitled, Effects of Pramlintide on Postprandial Glucose Excursions and Measures of Oxidative Stress in Patients With Type 1 Diabetes
Open the PDF for Effects of Pramlintide on Postprandial Glucose Excursions and Measures of Oxidative Stress in Patients With Type 1 Diabetes in another window
Journal Articles

Pramlintide Reduces Postprandial Glucose Excursions When Added to Regular Insulin or Insulin Lispro in Subjects With Type 1 Diabetes: A dose-timing study

Free
Christian Weyer, MD, Alan Gottlieb, PA, Dennis D. Kim, MD, Karen Lutz, PHD, Sherwyn Schwartz, MD, Maria Gutierrez, MD, Yan Wang, PHD, James A. Ruggles, PHD, Orville G. Kolterman, MD, David G. Maggs, MD
Journal: Diabetes Care
Diabetes Care 2003;26(11):3074–3079
https://doi.org/10.2337/diacare.26.11.3074
Published: 01 November 2003
View articletitled, Pramlintide Reduces Postprandial Glucose Excursions When Added to Regular Insulin or Insulin Lispro in Subjects With Type 1 Diabetes: A dose-timing study
Open the PDF for Pramlintide Reduces Postprandial Glucose Excursions When Added to Regular Insulin or Insulin Lispro in Subjects With Type 1 Diabetes: A dose-timing study in another window
Journal Articles

Pramlintide as an Adjunct to Insulin Therapy Improves Long-Term Glycemic and Weight Control in Patients With Type 2 Diabetes: A 1-year randomized controlled trial

Free
Priscilla A. Hollander, MD, Philip Levy, MD, Mark S. Fineman, BS, David G. Maggs, MD, Larry Z. Shen, PHD, Susan A. Strobel, PHD, Christian Weyer, MD, Orville G. Kolterman, MD
Journal: Diabetes Care
Diabetes Care 2003;26(3):784–790
https://doi.org/10.2337/diacare.26.3.784
Published: 01 March 2003
View articletitled, Pramlintide as an Adjunct to Insulin Therapy Improves Long-Term Glycemic and Weight Control in Patients With Type 2 Diabetes: A 1-year randomized controlled trial
Open the PDF for Pramlintide as an Adjunct to Insulin Therapy Improves Long-Term Glycemic and Weight Control in Patients With Type 2 Diabetes: A 1-year randomized controlled trial in another window
Journal Articles

Impact of Pramlintide on Glucose Fluctuations and Postprandial Glucose, Glucagon, and Triglyceride Excursions Among Patients With Type 1 Diabetes Intensively Treated With Insulin Pumps

Free
Claresa Levetan, MD, Laura L. Want, MS, Christian Weyer, MD, Susan A. Strobel, PHD, John Crean, PHD, Yan Wang, PHD, David G. Maggs, MD, Orville G. Kolterman, MD, Manju Chandran, MD, Sunder R. Mudaliar, MD, Robert R. Henry, MD
Journal: Diabetes Care
Diabetes Care 2003;26(1):1–8
https://doi.org/10.2337/diacare.26.1.1
Published: 01 January 2003
View articletitled, Impact of Pramlintide on Glucose Fluctuations and Postprandial Glucose, Glucagon, and Triglyceride Excursions Among Patients With Type 1 Diabetes Intensively Treated With Insulin Pumps
Open the PDF for Impact of Pramlintide on Glucose Fluctuations and Postprandial Glucose, Glucagon, and Triglyceride Excursions Among Patients With Type 1 Diabetes Intensively Treated With Insulin Pumps in another window
Journal Articles

A Randomized Study and Open-Label Extension Evaluating the Long-Term Efficacy of Pramlintide as an Adjunct to Insulin Therapy in Type 1 Diabetes

Free
Fred Whitehouse, MD, Davida F. Kruger, MSN, Mark Fineman, BS, Larry Shen, PHD, James A. Ruggles, PHD, David G. Maggs, MD, Christian Weyer, MD, Orville G. Kolterman, MD
Journal: Diabetes Care
Diabetes Care 2002;25(4):724–730
https://doi.org/10.2337/diacare.25.4.724
Published: 01 April 2002
View articletitled, A Randomized Study and Open-Label Extension Evaluating the Long-Term Efficacy of Pramlintide as an Adjunct to Insulin Therapy in Type 1 Diabetes
Open the PDF for A Randomized Study and Open-Label Extension Evaluating the Long-Term Efficacy of Pramlintide as an Adjunct to Insulin Therapy in Type 1 Diabetes in another window